U.S. markets closed
  • S&P Futures

    3,761.00
    -4.50 (-0.12%)
     
  • Dow Futures

    30,844.00
    -34.00 (-0.11%)
     
  • Nasdaq Futures

    12,428.50
    -26.50 (-0.21%)
     
  • Russell 2000 Futures

    2,140.00
    -4.50 (-0.21%)
     
  • Crude Oil

    64.37
    +0.54 (+0.85%)
     
  • Gold

    1,689.50
    -11.20 (-0.66%)
     
  • Silver

    25.25
    -0.21 (-0.81%)
     
  • EUR/USD

    1.1966
    -0.0013 (-0.11%)
     
  • 10-Yr Bond

    1.5500
    +0.0800 (+5.44%)
     
  • Vix

    28.57
    +1.90 (+7.12%)
     
  • GBP/USD

    1.3895
    +0.0002 (+0.01%)
     
  • USD/JPY

    108.0600
    +0.0840 (+0.08%)
     
  • BTC-USD

    47,106.64
    -3,548.78 (-7.01%)
     
  • CMC Crypto 200

    941.19
    -46.02 (-4.66%)
     
  • FTSE 100

    6,650.88
    -24.59 (-0.37%)
     
  • Nikkei 225

    28,744.84
    -185.27 (-0.64%)
     

Bio-Rad: 4Q Earnings Snapshot

·1 min read

HERCULES, Calif. (AP) _ Bio-Rad Laboratories Inc. (BIO.B) on Thursday reported fourth-quarter earnings of $839.1 million.

The Hercules, California-based company said it had net income of $27.81 per share. Earnings, adjusted for non-recurring gains, were $4.01 per share.

The maker of instruments used in biomedical research posted revenue of $789.8 million in the period.

For the year, the company reported profit of $3.81 billion, or $126.20 per share. Revenue was reported as $2.55 billion.

Bio-Rad shares have increased 11% since the beginning of the year. In the final minutes of trading on Thursday, shares hit $635, a rise of 72% in the last 12 months.

_____

This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on BIO.B at https://www.zacks.com/ap/BIO.B